Cargando…

Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Lin, Junhao, Chen, Zhi, Li, Zuan, Nong, Deyong, Li, Ximing, Huang, Guihai, Hao, Nan, Liang, Jianbo, Li, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204534/ https://www.ncbi.nlm.nih.gov/pubmed/35674160 http://dx.doi.org/10.3892/or.2022.8343

Ejemplares similares

Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer
por: Lin, Junhao, et al.
Publicado: (2021)

The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue
por: Li, Ximing, et al.
Publicado: (2020)

Speckle-type POZ protein could play a potential inhibitory role in human renal cell carcinoma
por: Chen, Zhi, et al.
Publicado: (2022)

CD44 regulates prostate cancer proliferation, invasion and migration via PDK1 and PFKFB4
por: Li, Wei, et al.
Publicado: (2017)

Effect of AKT silence on malignant biological behavior of renal cell carcinoma cells
por: Li, Zuan, et al.
Publicado: (2022)

Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”
por: Durko, L., et al.
Publicado: (2017)

High expression of TTC21A predicts unfavorable prognosis and immune infiltrates in clear cell renal cell carcinoma
por: Lin, Junhao, et al.
Publicado: (2022)

Minicircle DNA-Mediated CAR T Cells Targeting CD44 Suppressed Hepatocellular Carcinoma Both in vitro and in vivo [Corrigendum]
Publicado: (2020)

RNAcentral: a hub of information for non-coding RNA sequences
Publicado: (2019)

Mechanism of activation of methyltransferases involved in translation by the Trm112 ‘hub’ protein
por: Liger, Dominique, et al.
Publicado: (2016)

HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum]
Publicado: (2019)

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
por: Mikropoulos, Christos, et al.
Publicado: (2018)

Corrigendum to ‘CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours’ [EBioMedicine 49 (2019) 82–95]
por: Vega, Francisco M., et al.
Publicado: (2020)

Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells
por: Desai, Bhavik, et al.
Publicado: (2007)

Genome-wide screening for cis-regulatory variation using a classical diallel crossing scheme
por: Kiekens, Raphaël, et al.
Publicado: (2007)

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study [Corrigendum]
Publicado: (2018)

Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events
Publicado: (2015)

Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection [Corrigendum]
Publicado: (2021)

A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma
por: Wang, Yonggang, et al.
Publicado: (2019)

Corrigendum to “Optimization and Corroboration of the Regulatory Pathway of p42.3 Protein in the Pathogenesis of Gastric Carcinoma”
por: Hao, Yibin, et al.
Publicado: (2015)

Corrigendum to “The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer”
por: Al-Shamsi, Humaid O., et al.
Publicado: (2017)

Corrigendum to “Gallic acid mediates tumor-suppressive effects on osteosarcoma through the H19-Wnt/β-catenin regulatory axis” [J. Orthop. Translat. 39 (2023) 34–42].
por: Pang, Fengxiang, et al.
Publicado: (2023)

Correction of Ethics Statement: Metastatic Insulinoma Presenting as a Liver Cyst
por: Li, Hua, et al.
Publicado: (2019)

Corrigendum to Clinical outcomes of volume of disease on patients receiving enzalutamide vs. abiraterone acetate plus prednisone as first-line therapy for metastatic castration resistant prostate cancer
Publicado: (2023)

Corrigendum to “Dietary Magnesium Intake and Leukocyte Telomere Attrition in Adults: The Regulatory Role of Serum Tumor Necrosis Factor α”
por: Yu, Jie, et al.
Publicado: (2020)

A report of 2 cases of Cornelia de Lange syndrome (CdLS) and an analysis of clinical and genetic characteristics in a Chinese CdLS cohort
por: Li, Shuo, et al.
Publicado: (2020)

Intratumoral immune heterogeneity of prostate cancer characterized by typing and hub genes
por: Han, Jianpeng, et al.
Publicado: (2022)

Corrigendum to “A serologic investigation of epizootic hemorrhagic disease virus in China between 2014 and 2019” [Virologica Sinica 37 (2022) 513–520]
por: Duan, Yingliang, et al.
Publicado: (2022)

Corrigendum to “poFUT1 promotes endometrial decidualization by enhancing the O-fucosylation of Notch1” [EBioMedicine 44 (2019) 563–573]
por: Yang, Yu, et al.
Publicado: (2023)

miR-505 suppresses prostate cancer progression by targeting NRCAM
por: Ling, Xiao-Hui, et al.
Publicado: (2020)

Corrigendum to “GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)”
Publicado: (2022)

Corrigendum: Incorrect Spelling of Author's Name: US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses
por: Gejerman, Glen, et al.
Publicado: (2018)

EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2
por: Chen, Shengnan, et al.
Publicado: (2020)

Corrigendum to “Pandemic stress and SARS-CoV-2 infection are associated with pathological changes at the maternal-fetal interface” [Placenta 115 (2021) 37–44]
por: Brien, Marie-Eve, et al.
Publicado: (2022)

[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
por: Ji, Junpeng, et al.
Publicado: (2023)

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992–2003
por: Clarke, N.W., et al.
Publicado: (2020)

Corrigendum to ‘Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer’. [EBioMedicine 31 (2018) 267–275>
por: Gan, Yu, et al.
Publicado: (2020)

Corrigendum to “The Story of CD4(+)CD28(−) T Cells Revisited: Solved or Still Ongoing?”
por: Maly, Kathrin, et al.
Publicado: (2015)

PLCε knockdown enhances the radiosensitivity of castration-resistant prostate cancer via the AR/PARP1/DNA-PKcs axis
por: Pu, Jun, et al.
Publicado: (2022)

Corrigendum to “Antroquinonol Exerts Immunosuppressive Effect on CD8(+) T Cell Proliferation and Activation to Resist Depigmentation Induced by H(2)O(2)”
por: Guan, Cuiping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_on7h4c71dg5chj80p883mvcc4g